RFQ S-44000-00016442_Clinician Advisory Services.pdf

RFQ S-44000-00016442 Clinician Advisory Services Page 1 of 7

Department of Consumer and Business Services Central Services Division, Procurement Section

350 Winter Street NE Salem, OR 97301

REQUEST FOR QUOTE (RFQ)

Intermediate Solicitation Bid #S-44000-00016442

Clinician Advisory Services

***THIS IS NOT AN ORDER***

Submit your Offer information by 2:00 PM Pacific Time on April 10, 2026

Single Point of Contact (SPC): Daniel Robinson, Procurement Specialist 350 Winter Street NE, Room 2 Salem, OR 97301

(503) 302-9747 daniel.k.robinson@dcbs.oregon.gov

1. Overview

This Request for Quote (RFQ) is issued by the State of Oregon, Department of Consumer and Business Services, Division of Financial Regulation (Agency) to seek Offers for Clinical Advisory Services.

All costs incurred in preparing and submitting a response to this RFQ will be the responsibility of the Offeror and will not be reimbursed by the State of Oregon.

Agency anticipates the award of one(1) Contract from this solicitation. The initial term of the Contract is anticipated to be two(2) years with option to extend.

Agency has authority under ORS 731.216 to solicit for these services. This RFQ is submitted pursuant to ORS 279B.070 and OAR 137-047-0270.

RFQ S-44000-00016442 Clinician Advisory Services Page 2 of 7

2. Definition of Terms

For purposes of this RFQ and resulting Contract, the following acronyms are defined as follows:

a. Project Specific Definitions

Capitalized terms not specifically defined in this document are defined in OAR 125-246- 0110.

• “DPT” means Drug Price Transparency team or work

• “PDAB” means Prescription Drug Affordability Board

• “PharmD” means Doctor of Pharmacy Degree

• “RFQ” means Request for Quote

• “Offer” means proposals submitted in response to this RFP.

• “Offeror” means an organization or vendor who submits an Offer to this solicitation.

b. Crosswalk of Terms used in OregonBuys

• “Amendment” means “Addendum” or “Addenda”, as defined in OAR 125-246- 0110(1); or any form of notice associated with the solicitation, such as intent to award, cancellation, etc., as set forth in the Amendment.

• “Bid Opening” means “Closing” as defined in OAR 125-246-0100(26). In OregonBuys it is the deadline for submitting Quotes (Bids, Proposals, or other required responses) required by a Bid Solicitation.

• “Bid Solicitation” means any form of opportunity, solicitation or notice: Request for Proposal, Invitation to Bid, Request for Quote, Request for Information, etc., including notices (sole source notice, intent to participate, etc.). Each Bid Solicitation has a separate page and ID number in OregonBuys.

• “Quote” means any form of offer submission by vendors; i.e., Bids, Proposals, Price Proposals, or any other type of offer required by a Bid Solicitation.

3. Background

The Department of Consumer and Business Services (DCBS) is Oregon’s largest regulatory and consumer protection agency. It administers state laws and rules, protects consumers and workers in the areas of workers’ compensation, occupational safety and health, financial services, insurance and building codes.

The Division of Financial Regulation (DFR) is a division of DCBS and oversees the financial and insurance industries in Oregon. It regulates insurance, depository institutions, trust companies, securities and consumer financial products and services. (e.g., mortgage lending, small dollar loans, collection agencies).

The Oregon Legislature established the Prescription Drug Affordability Board (“Board”) in 2021 through Senate Bill 844, and Board members began meeting in June 2022. Under ORS https://olis.oregonlegislature.gov/liz/2021R1/Downloads/MeasureDocument/SB844/Enrolled

RFQ S-44000-00016442 Clinician Advisory Services Page 3 of 7

646A.693 to 646A.697, the Board is charged with protecting Oregon residents, state and local governments, commercial health plans, health care providers, pharmacies licensed in Oregon, and other stakeholders within the health care system from the high costs of prescription drugs. The Board is established and supported within DFR and has a legislatively mandated business need to evaluate price concessions, discounts, and rebates that drug manufacturers provide to pharmacy benefit managers and health insurance plans, including those associated with therapeutic alternatives. This information is essential for the Board to conduct affordability reviews and make determinations consistent with ORS 646A.694.

4. Issues and Needs

The Board and Agency are looking for ongoing clinical advisory services to support staff assigned to the Board as well as staff supporting the Drug Pricing Transparency Program.

These services include evaluations that focus on the applicability and clinical details of drugs subject to legislatively mandated Board affordability reviews, the identification of therapeutic alternatives to drugs under review, and development of other clinical information, such as dosage and treatment duration, to inform PDAB and DPT analyses.

5. Objectives

The objective of this RFQ is to receive bids to perform the following work:

a. Nature of work:

i. Provide Agency staff clinical advisory services to support analysis of prescription drugs and their therapeutic alternatives that are considered and selected as part of affordability reviews. This includes:

a. Attend meetings scheduled by Agency.

b. Communicate in a timely manner with staff (one(1) business day response by text or email).

c. Create supporting documents as requested by Agency.

d. Review and provide feedback on documents created by Agency, within the deadline provided.

ii. Provide Agency estimated work hours and rate for any documentation development or review before beginning work.

iii. Provide program development consultation to Agency staff as requested.

b. Deliverables:

Contractor shall provide ongoing clinical advisory services to Agency staff and Agency-identified stakeholders, focused on the applicability and details of drugs that are part of

RFQ S-44000-00016442 Clinician Advisory Services Page 4 of 7 the legislatively mandated Board affordability reviews. Agency staff may also request clinical advisory services to inform drug price transparency and affordability program analyses and work products in addition to the affordability reviews.

Deliverables will be assigned by Agency on an as needed basis and may include the following data for drugs under affordability review:

i. Developing a clinical profile that includes drug indications, dosing, clinical efficacy, clinical safety, and therapeutic alternatives.

ii. For specific prescription drugs under review as well as any therapeutic alternatives, confirm dose, frequency, National Drug Codes (NDCs), route of administration, dosage form(s), strength and/or strength of measure.

iii. Other additional or related information requested regarding drug under review or therapeutic equivalents and alternatives.

6. Contractor Minimum Qualifications

• Offeror must submit resumes for key person(s). At least one key person must have a Doctor of Pharmacy (PharmD) degree and be using it professionally.

• Experience consulting for public entities (city, county, state, federal) and any experience providing clinical information regarding drug reviews.

• Availability to support the board.

• Demonstrate must the Objectives in Section 5 can be performed to the expectation the Agency

• Must demonstrate no conflicts of interest exist.

7. Bids

Offeror must submit Attachment C – Quote Submission Form. Pricing listed in this submission will be a firm offer for 60 calendar days following the opening of the Offer.

8. Single Point of Contact (SPC)

All communications, including questions, comments, and requests for clarification must be in writing to the SPC listed on the front page and emailed to daniel.k.robinson@dcbs.oregon.gov by 2:00 pm Pacific Time on April 10, 2026. Questions via phone or any other method will not be

RFQ S-44000-00016442 Clinician Advisory Services Page 5 of 7 accepted.

9. RFQ Schedule

Issued Date: March 27, 2026 Questions and Clarifications Due: April 6, 2026 @ 2:00 PM (PT) Response Date to Questions and Clarifications: April 7, 2026 @ 3:00 PM (PT) OregonBuys Bid Opening (Closing) Date: April 10, 2026 @ 2:00 PM (PT)

10. RFQ Submission Process

Offers will be reviewed on a Pass/Fail basis. Failure to provide any of the information or comply with any of the requirements in this section 10 and its subsections MAY be considered nonresponsive. Agency has the right to determine if Offers substantially meet the requirements of this RFQ.

b. Submission Requirements

To be considered, Offerors must submit the following:

• Resumes of Key Persons

• Attachment B - Disclosure Exemption Affidavit (Optional)

• Attachment C - Offer Submission form

c. Offer Submissions Offeror should submit its Offer electronically through OregonBuys. Offeror should follow the procedures outlined in detailed instructions on how to submit an Offer can be found at OregonBuys Vendor Formal Solicitation Response.pdf

Responses must be received no later than Friday, April 10, 2026 by 2:00 PM Pacific Time to be considered

11. Procurement Process

The RFQ, including all Amendmentsi and attachments, are published in the OregonBuys e-procurement system. RFQ documents will not be mailed to prospective Offerors.

Agency shall advertise all Amendments on OregonBuys e-procurement system.

Prospective Offeror is solely responsible for checking OregonBuys to determine whether or not any Amendments have been issued. Amendments are incorporated into the RFQ by this reference.

https://www.oregon.gov/das/ORBuys/Documents/OregonBuys%20Vendor%20Formal%20Solicitation%20Response.pdf https://oregonbuys.gov/bso/view/login/login.xhtml

RFQ S-44000-00016442 Clinician Advisory Services Page 6 of 7

12. Public Records

The information received shall be kept by Agency and made a part of a file or record, which will be open to public inspection. If respondents believe any of its RFQ response is exempt from disclosure under Oregon Public Records law (ORS 192.311 through 192.478), respondent shall complete and submit the Affidavit of Trade Secret (Attachment B) an submit a fully redacted version of its information, clearly identified as the redacted version.

Identifying the Response in whole as exempt from disclosure is not acceptable. If submitter fails to identify the portions of the Response which submitter claims are exempt from disclosure, submitter is deemed to have waived any future claim of non-disclosure of that information.

13. Award Determination

The Agency will be reviewing responses for the Offer that will best serve the interests of the contracting Agency. Award determination will be based upon price. See attachment C – Quote Submission Form for more details. Agency reserves the right not to award a contract if it is in the best interest of the Agency.

14. Solicitation Terms

• All pricing must be held firm for 90 days.

• Protests will not be entertained.

• Agency may require clarification to understand any response

• Agency reserves the right to accept any Offer or any part or to reject any or all

Offers. Submission of a Offer does not constitute an agreement between Agency and Offeror, nor does it secure or imply that Offeror will be selected.

• If selected for award, Offeror shall be duly authorized by the State of Oregon to transact business in the State of Oregon before executing the Contract. Visit http://sos.oregon.gov/business/pages/register.aspx for Oregon Business Registry information.

15. Cancellation and/or Rejection of Offers Pursuant to ORS 279B.100, Agency may reject any or all Offers in whole or in part, and may cancel this RFQ at any time when the rejection or cancellation is in the best interest of the State. Agency, the State, and their officers, employees and agents are not liable to any Offeror for any loss or expense caused by or resulting from the delay, suspension, or cancellation of this RFQ, or rejection of any or all Bids. Unless Agency cancels this RFQ prior to the Closing identified in Section 9, all Bids will become part of the public record without obligation to Agency.

16. Other Required Information http://sos.oregon.gov/business/pages/register.aspx

RFQ S-44000-00016442 Clinician Advisory Services Page 7 of 7

a. Insurance:

Prior to award, Offeror shall secure and demonstrate to Agency proof of insurance as required in this RFQ. Insurance Requirements are found in Exhibit B of Attachment A.

b. Tax Identification Number:

The apparent successful Offeror shall provide its Taxpayer Identification Number (TIN) and backup withholding status on a completed W-9 form if either of the following applies:

• When requested by Agency (normally in an intent to award notice), or

• When the backup withholding status or any other information of Offeror has changed since the last submitted W-9 form, if any.

Agency will not execute the Contract until Agency has a properly completed W-9.

c. Business Registry:

If selected for award, Offeror shall be duly authorized by the State of Oregon to transact business in the State of Oregon before executing the Contract. The selected Offeror shall submit a current Oregon Secretary of State Business Registry number, or an explanation if not applicable.

All Corporations and other business entities (domestic and foreign) must have a

Registered Agent in Oregon. See requirements and exceptions regarding Registered Agents. For more information, see Oregon Business Guide, How to Start a Business in Oregon and Laws and Rules. The titles in this subsection are available at the following Internet site: http://www.filinginoregon.com/index.htm.

17. Attachments:

• Attachment A – Sample Contract o Exhibit A – Statement of Work

• Attachment B – Disclosure Exemption Affidavit

• Attachment C – Offer Submission Form http://www.irs.gov/pub/irs-pdf/fw9.pdf http://www.filinginoregon.com/index.htm